Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
European Urology Oncology|January 24, 2025
Implications and Lessons from the Withdrawal of Sacituzumab Govitecan for Treating Advanced Urothelial CarcinomaDavid J Benjamin, Arash Rezazadeh Kalebasty, Nataliya MarEuropean Urology Oncology|March 14, 2024
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma?David J Benjamin, Arash Rezazadeh Kalebasty, Vinay PrasadClinical Medicine Insights. Oncology|October 3, 2022
Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial CarcinomaDavid J Benjamin, Nataliya Mar, Arash Rezazadeh KalebastyCancers|May 13, 2023
Prostate Cancer in Sexual Minorities: Epidemiology, Screening and Diagnosis, Treatment, and Quality of LifeOmid Yazdanpanah, David J Benjamin, Arash Rezazadeh KalebastyJournal of Cancer Policy|June 9, 2024
Social media engagement of supportive care publications in oncologySruthi Ranganathan, David J Benjamin, Alyson Haslam, et al.Gynecologic Oncology Reports|March 7, 2024
Cost effectiveness of immunotherapy combination therapies for endometrial cancerDavid J Benjamin, William V Padula, Robert C HsuCancer Medicine|March 22, 2022
Targeted therapy in lung cancer: Are we closing the gap in years of life lost?David J Benjamin, Alyson Haslam, Jenny Gill, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 22, 2018
New and emerging therapies for acute myeloid leukaemiaJulian R Davis, David J Benjamin, Brian A JonasCancer Treatment and Research Communications|July 14, 2022
Eponyms in Malignant HematologyDanielle Brazel, Priyanka Kumar, David J Benjamin, et al.Cancer Treatment and Research Communications|January 22, 2022
Eponyms in medical oncologyPriyanka Kumar, Danielle Brazel, David J Benjamin, et al.Pageof 9